1955 Primary Systemic Therapy by Dual HER2 Blockage with Lapatinib (la) + Trastuzumab (T) for Japanese Patients (pts) with HER2+ Breast Cancer (BC): Association of La Toxicity and Dose with Treatment Efficacy
European journal of cancer（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined